UrbanFisio Launches Virtual Assistant to Surpass €1 Million by 2021

UrbanFisio is accelerating its expansion. The company is developing a physiotherapy virtual assistant to underpin a new hybrid model that combines online and face-to-face treatment, which has meant an investment to date of $176,600 (€150,000).

The company had a turnover of $1.03 million (€878,000) in 2020 and expects to reach $1.53 million (€1.3 million) by the end of this year, which means a 50% increase in turnover. Since its birth in 2016, the company UrbanFisio has served a total of 20,000 customers and performed more than 80,000 treatments.

This complement to face-to-face manual therapies pivots on a web application and can be used in real-time from any device with an Internet connection that has a camera. It is not necessary to install any software to use it.

Read more about UrbanFisio and find the latest financial news in the world with our companion app Born2Invest.

The company had a turnover of $1.03 million (€878,000) in 2020 and expects to reach $1.53 million (€1.3 million) by the end of this year

The remote work method is based on the real-time analysis of the patient’s movement during exercise, offering guidance and motivational feedback remotely. Finally, the physiotherapy treatment and results are managed through an Artificial Intelligence (AI) system and integrated into the patient’s electronic medical record and exercise library.

The company, founded five years ago in Madrid by Miguel de Santiago, an economist, and Irma Gutiérrez, a physiotherapist, has set itself the goal of reaching 80% of the national territory. At the moment, UrbanFisio already has a foot in some of the most populated provinces of Spain such as Madrid, Barcelona, Valencia, Alicante, Bilbao, Asturias, Malaga, Seville, and Tenerife.

Among UrbanFisio’s future plans is a round of investment, of which the figures have not been disclosed, to implement the new hybrid model of physiotherapy care, a bet that revolves around three axes. The first is preventive and predictive medicine, based on the collection of clinical data; the second is personalized medicine, and the last is home medicine, focused on remote and continuous monitoring of the patient’s condition.

UrbanFisio expects to reach 90 employees by the end of 2021

The policy of continuous hiring that the company has been carrying out over the last year and a half aims to reach 90 employees by the end of 2021. At the moment, UrbanFisio has 50 physiotherapists on its payroll.

The company is investing in postgraduate training for its own workers. UrbanFisio is finalizing agreements with Universidad Pontificia Comillas, Universidad Alfonso X El Sabio and Universidad Nebrija, and is also in talks with Universidad Rey Juan Carlos and Universidad CEU-San Pablo.

__

(Featured image by andreas160578 via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in PlantaDoce, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.